No Picture
News

Unbabel’s 2021 Global Multilingual CX Survey Reveals 68% of Consumers Prefer to Speak with Brands in Their Native Language

SAN FRANCISCO–(BUSINESS WIRE)–Unbabel, an AI-powered Language Operations platform that helps businesses deliver multilingual support at scale, today announced the findings from its 2021 Global Multilingual CX Report. The survey shows that how speakin… […]

No Picture
News

Vertex and Mammoth Biosciences Announce Collaboration to Develop In Vivo Gene-Editing Therapies for Serious Diseases

BRISBANE, Calif.–(BUSINESS WIRE)– #CRISPR–Mammoth Biosciences advances CRISPR platform, partnering with Vertex Pharmaceuticals to develop in vivo gene-editing therapies for serious diseases. […]

No Picture
News

Anitoa Receives FDA Registration and Class II Exempt Device Listing for its Maverick Line of Portable qPCR Instruments

SUNNYVALE, Calif.: SUNNYVALE, Calif., Oct. 26, 2021 /PRNewswire/ — Anitoa Systems, LLC., a Silicon Valley biotechnology company and market leader in rapid, portable molecular testing hardware, today announced its Maverick line of qPCR instruments have… […]

No Picture
News

Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical Trial

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Oct. 26, 2021 /PRNewswire/ — Vaxart, Inc. (NASDAQ: VXRT) today announced that it has dosed the first subject in its Phase II COVID-19 oral tablet vaccine clinical trial, the only Phase II trial… […]

No Picture
News

Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study

SAN JOSE, Calif. and CLEVELAND: SAN JOSE, Calif. and CLEVELAND, Oct. 26, 2021 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa") a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, … […]

No Picture
News

Jennifer Doudna spinout inks a Mammoth CRISPR deal with Vertex worth nearly $700M

When a company gets its start in gene editing pioneer Jennifer Doudna’s lab, it’s bound to make headlines. But three years in, the fanfare still hasn’t died down for Mammoth Biosciences. Now, the Brisbane, CA-based company is cheering on its first majo… […]

No Picture
News

Rigel Announces Conference Call and Webcast to Report Third Quarter 2021 Financial Results and Business Update

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Oct. 26, 2021 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its third quarter 2021 financial results after market close on Tuesday, November 2, 20… […]

No Picture
News

Protagonist Therapeutics Earns $7.5 Million Milestone Payment from IL-23 Receptor Collaboration with Janssen

NEWARK, Calif.: NEWARK, Calif., Oct. 26, 2021 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that it will receive a $7.5 million milestone payment from Janssen Biotech,… […]